登录新浪财经APP 搜索【信披】查看更多考评等级 新京报贝壳财经记者 阎侠 编辑 岳彩周 校对 赵琳 两个月不到，2月4日又一份《立案告知书》摆在了倍轻松实控人马学军的面前。 从涉嫌信披违规到涉嫌操纵市场，监管目光持续聚焦的背后，还有实控人此前资金占用往事。 2月6日，倍轻松的股价开盘即下跌，截至收盘，其股价为22.71元/股，跌幅为1.13%，公司总市值约 19.52亿元。自2021年上市即巅峰后，这家公司的市值已较高峰时跌去超80%。 此前，公司发布了一份2025年归母净利润盈转亏的业绩预告，预亏金额亿元左右。记者注意到倍轻松业 绩波动较大，2021年和2024年盈利，2022年和2023年亏损，2025年预亏。而其扣非净利润已连续四年亏 损。 从涉嫌信披违规到涉嫌操纵市场 倍轻松实控人马学军两个月内收到两份立案告知书 2月5日晚间，倍轻松发布公告称，公司于2026年2月4日收到中国证监会对实际控制人马学军下发的《立 案告知书》，因其涉嫌操纵证券市场，根据相关法律法规，中国证监会决定对其立案。 值得一提的是，这已经是马学军在两个月内被下发的第二份《立案告知书》。2025年12月25日，倍轻松 收到中国证监 ...

Core Viewpoint - The company, Beiliang, is under investigation by the China Securities Regulatory Commission (CSRC) for alleged market manipulation involving its actual controller, Ma Xuejun, which may impact investor confidence and future operations [1][5]. Group 1: Investigation Details - On February 4, the CSRC issued a notice to Ma Xuejun regarding the investigation for suspected market manipulation [1]. - This investigation is separate from a previous case in December 2022, where both the company and Ma Xuejun were investigated for information disclosure violations [5]. Group 2: Company Operations - Beiliang stated that the investigation pertains to Ma Xuejun personally and will not significantly affect the company's daily operations, with him continuing to fulfill his duties [3][4]. - The company is committed to complying with legal and regulatory requirements and will keep stakeholders informed about the investigation's progress [4]. Group 3: Financial Performance - Beiliang is a high-tech enterprise focused on the innovation and development of health products, primarily engaged in the design, research, production, sales, and service of smart portable health hardware [7]. - The latest earnings forecast indicates that the company expects to report a net loss of between 84 million to 105 million yuan for 2025, marking a shift from profit to loss [7]. - As of February 5, Beiliang's stock closed at 22.97 yuan per share, reflecting a 0.75% increase, with a total market capitalization of 1.974 billion yuan [7].

Core Viewpoint - The company Beilingsong (倍轻松) is under investigation by the China Securities Regulatory Commission (CSRC) for alleged violations of information disclosure laws, which has led to a significant drop in its stock price and raised concerns about its financial stability [2][3]. Company Overview - Beilingsong is a high-tech enterprise focused on the innovation, research, and development of health products, primarily engaged in the design, production, and sales of smart portable health hardware [3]. - The company has a current market capitalization of 1.943 billion yuan [2][3]. Financial Performance - For the first three quarters of 2025, Beilingsong reported a revenue of 552 million yuan, with a net profit attributable to shareholders of -29.51 million yuan in the third quarter [4]. - The company’s actual controller, Ma Xuejun, recently reduced his stake by transferring 2.97% of the total shares, raising approximately 64.71 million yuan [4]. Recent Developments - On December 25, 2025, the CSRC issued a notice of investigation to Beilingsong and its actual controller Ma Xuejun for suspected information disclosure violations [2]. - In response to the investigation, the company stated that its business operations remain normal and it will cooperate with the CSRC [2]. - Prior to the investigation notice, Ma Xuejun executed a significant share sale, contrasting with another major shareholder, Wang Qiaoqing, who decided to terminate a planned share reduction, citing confidence in the company's long-term development [4]. Capital Needs - On December 23, 2025, just two days before the investigation notice, Beilingsong announced the completion of certain fundraising projects and the decision to permanently supplement its working capital with 19.21 million yuan from the remaining funds [5].

【导读】倍轻松及实控人涉嫌信息披露违法违规被证监会立案 中国基金报记者 闻言 12月25日晚间，倍轻松发布公告称，公司及实控人马学军当日收到中国证监会下发的《立案告知书》。 《立案告知书》显示，因涉嫌信息披露违法违规，根据相关法律法规，中国证监会决定对倍轻松及马学 军立案。 | 报告期末普通股股东总 | | 5.073 | | | 报告期末表决权恢复 的优先股股东总数(如 | | 0 | | --- | --- | --- | --- | --- | --- | --- | --- | | 教 | | | | | | | | | | | | | 有) | | | | | | | 前10名股东持股情况(不含通过转融通出借股份) | | | | | | | | | | 持股 | 持有有限 | 包含转融 | | 质押、标记或 冻结情况 | | | 股东性 | | | | 通借出股 | | | | 股东名称 | | 持股数量 | 比例 | 售条件股 | | | | | | 质 | | (%) | 份数量 | 份的限售 | 股份 | 数 | | | | | | | 股份数量 | 状态 | 量 | | 马学军 | 境内自 ...

【导读】倍轻松及实控人涉嫌信息披露违法违规被证监会立案 12月25日晚间，倍轻松发布公告称，公司及实控人马学军当日收到中国证监会下发的《立案告知书》。 《立案告知书》显示，因涉嫌信息披露违法违规，根据相关法律法规，中国证监会决定对倍轻松及马学军立案。 | 稀释每股收益(元/股)_本报告期 | 不适用 | | --- | --- | | 稀释每股收益(元/股)_年初至报 | -593.75 | | 告期末 | | 简历显示，马学军生于1971年4月，自2001年8月至今担任倍轻松董事长、总经理，全面负责倍轻松的经营管理。2024年，马学 军从倍轻松获得的税前薪酬为115.93万元。 截至2025年第三季度末，马学军直接持有倍轻松40.48%的股份，并通过宁波赫廷投资有限公司、宁波日松企业管理合伙企业 （有限合伙）、宁波倍润投资有限公司，合计间接控制倍轻松12.66%的股份。 | 甲仪:胶 | | | | | | | | | 报告期末表决权恢复 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 报告期末普通股股东总 ...

【 导读 】 倍轻松及实控人涉嫌 信息披露 违法违规 被 证监会立案 中国基金报记者 闻言 12月25日 晚间 ，倍轻松 发布公告称， 公司及实控人马学军 当日 收到中国证监会下发的 《立案告知书》 。 《 立案告知书 》 显示， 因涉嫌信息披露违法违规，根据相关法律法规，中国证监会决定对 倍轻松 及马学军立案。 简历显示， 马学军 生于 1971年4月， 自 2001年8月至今 担任 倍轻松董事长、总经理，全 面负责 倍轻松 的经营管理 。 2024年，马学军从倍轻松获得的税前薪酬为 115.93 万元。 截至2025年第三季度末，马学军直接持有倍轻松40.48%的股份，并通过宁波赫廷投资有限 公司、宁波日松企业管理合伙企业（有限合伙）、宁波倍润投资有限公司，合计间接控制倍 轻松12.66%的股份。 深圳市倍轻松科技股份有限公司 2025年第三季度报告 | 报告期末普通股股东总 | | | | | 报告期末表决权使复 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 世 | | 5.073 | | | 的优先政政东总数(如 | ...